UK markets close in 1 hour 41 minutes

Lifecome Biochemistry Co.,Ltd. (002868.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
13.17-0.97 (-6.86%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.20B
Enterprise value 3.05B
Trailing P/E 55.89
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.91
Price/book (mrq)5.76
Enterprise value/revenue 5.38
Enterprise value/EBITDA -71.07

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3-59.93%
S&P500 52-week change 326.24%
52-week high 337.43
52-week low 313.01
50-day moving average 315.97
200-day moving average 321.00

Share statistics

Avg vol (3-month) 32.52M
Avg vol (10-day) 31.02M
Shares outstanding 5155.42M
Implied shares outstanding 6155.42M
Float 837.5M
% held by insiders 171.78%
% held by institutions 10.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.24
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 421 May 2021
Last split factor 21.3:1
Last split date 328 May 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -42.84%
Operating margin (ttm)-8.34%

Management effectiveness

Return on assets (ttm)-8.19%
Return on equity (ttm)-50.11%

Income statement

Revenue (ttm)567.21M
Revenue per share (ttm)3.61
Quarterly revenue growth (yoy)60.10%
Gross profit (ttm)N/A
EBITDA -134.72M
Net income avi to common (ttm)-243.02M
Diluted EPS (ttm)-1.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)32.29M
Total cash per share (mrq)0.21
Total debt (mrq)1.09B
Total debt/equity (mrq)283.15%
Current ratio (mrq)0.51
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-140.08M
Levered free cash flow (ttm)-474.35M